Progress in understanding of autoinflammatory syndromes and how they have triggered the exploration of the role of innate immunity in common rheumatologic diseases is reviewed. Current Opinion in Rheumatology
How is the performance of assays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in small vessel vasculitis and treated vasculitis or nonvasculitic disease? American Journal of Clinical Pathology
Reduction of elevated tumor necrosis factor (TNF)-alpha levels after infliximab treatment does not predict treatment response in patients with rheumatoid arthritis (RA), according to a report in the November issue of The Journal of Rheumatology. Reuters Health Information
Review treatment decisions in patients with RA during the initial diagnosis; in patients who have inadequate response to maximal disease-modifying antirheumatic drugs; and treatment failures.
